Inactive Instrument
Aimmune Therapeutics, Inc. Stock
Stocks
AIMT
US00900T1079
Biotechnology & Medical Research
| 1 day | -0.29% |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 13/10/20 | Others | Director | 109,372 | 0.1671% | ||
| 13/10/20 | Nestle Health Science SA (Private Equity)
| Buy | Company | 54,117,287 | 82.6848% | |
| 10/10/20 | Tender | General Counsel | 391,686 | 0.5984% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.29% | +0.20% | - | - | 2.27B | |
| -0.81% | -0.33% | +27.15% | +81.12% | 55.6B | |
| -3.74% | -6.32% | +42.70% | +64.45% | 55.2B | |
| -0.11% | +0.86% | -15.63% | -13.56% | 23.51B | |
| -1.58% | -5.51% | -3.51% | +375.36% | 22.35B | |
| +2.54% | -0.56% | +20.75% | -11.84% | 20.6B | |
| -1.23% | -3.15% | +26.00% | -31.88% | 17.45B | |
| +1.37% | -4.86% | +17.55% | +547.25% | 15.16B | |
| +1.16% | +0.58% | +51.87% | +181.96% | 13.91B | |
| -5.09% | -10.87% | +153.11% | +272.20% | 13.74B | |
| Average | -0.72% | -1.55% | +35.55% | +162.79% | 26.39B | |
| Weighted average by Cap. | -1.17% | -0.46% | +31.12% | +125.92% |
Employees
-
